Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis
MI Lassenius, I Toppila, N Pöntynen… - European clinical …, 2020 - Taylor & Francis
Aim of the study: Potential care implications of antifibrotic reimbursement restrictions were
studied by forced vital capacity (FVC) decline, mortality and specialty care related healthcare …
studied by forced vital capacity (FVC) decline, mortality and specialty care related healthcare …
Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
WM Reichmann, YF Yu, D Macaulay, EQ Wu… - BMC pulmonary …, 2015 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a rare and serious disease characterized
by progressive lung-function loss. Limited evidence has been published on the impact of …
by progressive lung-function loss. Limited evidence has been published on the impact of …
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the …
J Behr, A Prasse, H Wirtz, D Koschel… - European …, 2020 - Eur Respiratory Soc
Objective There is a paucity of observational data on antifibrotic therapy for idiopathic
pulmonary fibrosis (IPF). We aimed to assess the course of disease of IPF patients with and …
pulmonary fibrosis (IPF). We aimed to assess the course of disease of IPF patients with and …
Hospitalizations in patients with idiopathic pulmonary fibrosis
HJ Kim, LD Snyder, A Adegunsoye, ML Neely… - Respiratory …, 2021 - Springer
Background Hospitalizations are common among patients with idiopathic pulmonary fibrosis
(IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF …
(IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF …
A small change in FVC but a big change for IPF: defining the minimal clinically important difference
J Behr - American journal of respiratory and critical care …, 2011 - atsjournals.org
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease associated with a
dismal prognosis and a median survival of approximately 3 years. However, in clinical …
dismal prognosis and a median survival of approximately 3 years. However, in clinical …
[HTML][HTML] Body mass index—percent forced vital capacity—respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients
T Kishaba, H Nagano, Y Nei… - Journal of Thoracic …, 2016 - ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is relentless progressive interstitial lung
disease. Evaluating predictor of mortality for IPF patients is crucial. The aim of this study was …
disease. Evaluating predictor of mortality for IPF patients is crucial. The aim of this study was …
[HTML][HTML] Hospital-based resource use and costs among patients with idiopathic pulmonary fibrosis enrolled in the idiopathic pulmonary fibrosis prospective outcomes …
Y Fan, SD Bender, CS Conoscenti, L Davidson-Ray… - Chest, 2020 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a rare and serious condition that is
associated with high health-care resource use. The goal of this study was to estimate …
associated with high health-care resource use. The goal of this study was to estimate …
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three …
MT Durheim, HR Collard, RS Roberts… - The Lancet …, 2015 - thelancet.com
Background Mortality is an impractical primary endpoint for clinical trials in patients with
idiopathic pulmonary fibrosis who have mild-to-moderate physiological impairment because …
idiopathic pulmonary fibrosis who have mild-to-moderate physiological impairment because …
Clinical management and acute exacerbations in patients with idiopathic pulmonary fibrosis in Spain: results from the OASIS study
E Cano-Jiménez, AD Romero Ortiz, A Villar… - Respiratory …, 2022 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease associated with
decline in lung function and poor prognosis entailing significant impairment in quality of life …
decline in lung function and poor prognosis entailing significant impairment in quality of life …
Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
Background Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a variable
course. Not uncommonly, IPF patients are hospitalized for respiratory-related causes …
course. Not uncommonly, IPF patients are hospitalized for respiratory-related causes …